Trials / Completed
CompletedNCT00899379
Treatment of Multiple Attacks of Acute Migraine (0462-025)
A Randomized, Triple-Blind, Placebo-Controlled, Outpatient Study to Examine the Safety and Efficacy of MK462 10 mg p.o. in the Treatment of Multiple Attacks of Migraine Headache
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 473 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A study to evaluate rizatriptan for the treatment of multiple attacks of acute migraine compared to placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | rizatriptan benzoate | Rizatriptan 10 mg p.o. at onset of moderate to severe migraine headache |
| DRUG | Comparator: Placebo | Placebo to Rizatriptan, Oral Tablet |
Timeline
- Start date
- 1995-04-01
- Primary completion
- 1996-01-01
- Completion
- 1996-04-01
- First posted
- 2009-05-12
- Last updated
- 2022-02-03
- Results posted
- 2010-07-15
Source: ClinicalTrials.gov record NCT00899379. Inclusion in this directory is not an endorsement.